Dr. Allegretta is Vice President of Research at the National MS Society, whose responsibilities include providing leadership and direction for the Society’s commercial and domestic research portfolio, including partnerships developed through Fast Forward.
He works to engage the academic and commercial research community to develop innovative solutions for MS treatments, and works with other members of the research team to assure integration and alignment of commercial research programs with the Society's overall research goals. He joined the Society in 2014 with 28 years of experience in biotechnology and pharmaceutical operations. Most recently, he was President, Chief Scientific Officer and Co-founder of BioMosaics Inc. in Burlington, Vermont, where he managed all aspects of cancer biomarker development, licensing and business partnerships. Prior to that, he worked in various positions at InterMune Pharmaceuticals and Connetics Corporation. Mark earned his Bachelor’s degree from Hartwick College and his PhD in Cellular and Molecular Biology from the University of Vermont. He was the recipient of a National MS Society postdoctoral fellowship at Stanford University.